ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1964

Changes in Soluble CD18 Reflect Latency in the Immune System and Predict Radiographic Progression in Early Rheumatoid Arthritis

Tue Wenzel Kragstrup1, Babak Jalilian1, Kresten Krarup Keller2, Kristian Stengaard-Pedersen3, Merete Lund Hetland4, Kim Hørslev-Petersen5, Peter Junker6, Mikkel Østergaard4, Ellen Margrethe Hauge7,8, Malene Hvid1, Thomas Vorup-Jensen1 and Bent Deleuran1,3, 1Department of Biomedicine, Aarhus University, Aarhus, Denmark, 2Aarhus University Hospital, Aarhus, Denmark, 3Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 4Glostrup University Hospital, Glostrup, Denmark, 5Research Unit at King Christian X Hospital for Rheumatic Diseases, Graasten, Denmark, 6Odense University Hospital, Odense, Denmark, 7Dept. of Anatomi, Aarhus University, Aarhus, Denmark, 8Rheumatology, Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Biomarkers, Inflammation, Integrins, mouse model and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Session Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

In early rheumatoid arthritis (RA), clinical disease characterized by swollen and painful joints is caused by synovitis. However, presence of autoantibodies may precede the clinical onset of RA by several years, and joint damage can progress despite clinical remission. Therefore, early and aggressive synovitis suppression has become the principal goal in “treat-to-target” strategies. However, the temporal changes of  immune system abnormalities during therapy and their significance remain poorly understood. Previously, we found a negative consequence of having low levels of the soluble form of CD18 (sCD18) in patients with chronic RA and spondyloarthritis1,2. Here, we study changes in plasma sCD18 levels in patients with early RA during a treat-to-target strategy (the OPERA regimen)3, during arthritogenesis in a murine model of chronic inflammatory polyarthritis (the SKG model) and in RA mononuclear cell cultures.

Methods

The level of sCD18 in plasma was analyzed with a time-resolved immunoflourometric assay in a study population of 152 patients with early treatment naïve RA at baseline and after 3, 6, and 12 months of treatment and during induced arthritogenesis in SKG mice. In vitro, synovial fluid mononuclear cells (SFMCs) and peripheral blood mononuclear cells (PBMCs) from 9 RA patients were cultured with either TNFα (40 ng/ml) or adalimumab (5μg/ml) for 48 hours. Data are expressed as median and IQR.

Results

Plasma levels of sCD18 were decreased in early RA patients at baseline (958.7 (766.2-1243) mU/ml) compared with healthy controls (HC) (1001 (872.0-1355) mU/ml) (P<0.05). The sCD18 plasma levels decreased further by 11% after 3 months  (P<0.05), but after 12 months of treatment the levels returned to those of HC. The sCD18 increment between 3 and 12 months was most pronounced in patients who achieved an early ACR response compared with non-responders (P<0.05). Changes in plasma sCD18 between baseline and 12 months associated inversely with progression in total Sharpe score (rho=-0.18, P<0.05) and joint space narrowing (rho=-0.23, P<0.01) at the 24-month radiographic follow-up. Similarly, the serum level of sCD18 was decreased in SKG mice 6 weeks after arthritis induction (249 (151-282) mU/ml) compared with control SKG mice (334 (313-403) mU/ml) (P<0.05) and exhibited a biphasic course after arthritis induction with an initial increase above baseline (P<0.05) followed by a decline to levels below baseline (P<0.05). In vitro, shedding of CD18 from RA SFMC and RA PBMC cultures were increased 2-3 fold by TNFα (both P<0.01) and decreased by adalimumab (P<0.05 and P<0.01, respectively).

Conclusion

Concordant biphasic temporal patterns of sCD18 were observed in early RA and in a murine model of chronic inflammatory polyarthritis. The late increase in sCD18 was particularly pronounced in patients who achieved and early ACR response and may reflect latency in immune system restoration pertaining to the course of future radiographic progression.

References

1. Gjelstrup et al, J. Immunol., 2010.

2. Kragstrup et al, Arthritis Res Ther, 2014.

3. Hørslev-Petersen et al, ARD, 2013.


Disclosure:

T. W. Kragstrup,
None;

B. Jalilian,
None;

K. K. Keller,
None;

K. Stengaard-Pedersen,
None;

M. Lund Hetland,
None;

K. Hørslev-Petersen,
None;

P. Junker,
None;

M. Østergaard,

Abbott/Abbvie, Centocor, Merck, Schering-Plough,

2,

Abbott/Abbvie, BMS, Boehringer-Ingelheim, Eli-Lilly, Centocor, GSK, Janssen, Merck, Mundipharma, Novo, Pfizer, Schering-Plough, Roche UCB, Wyeth,

5;

E. M. Hauge,
None;

M. Hvid,
None;

T. Vorup-Jensen,
None;

B. Deleuran,
None.

  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/changes-in-soluble-cd18-reflect-latency-in-the-immune-system-and-predict-radiographic-progression-in-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.